baber/WOPTO huggingface dataset:
Patent AU-2002231069-B2 (AU)
Title: Antimicrobial medical devices
Inventor: SAMPATH LESTER A
IPC: A61L29/00
Filed: 2001-12-21
Granted: 2007-07-26
Abstract: The present disclosure invention relates to medical devices treated with a solution comprising one or more solvents and a combination of chlorhexidine free base and a water-soluble chlorhexidine salt in a weight/weight ratio of between about 1:1 to about 1:5, preferably about 1:1.
Patent AU-2002251957-B2 (AU)
Title: Gas permeable sterile closure
Inventor: TIMMINS WILLIAM D
IPC: B65D90/00
Filed: 2002-02-14
Granted: 2005-09-01
Abstract: A container (10) having a plurality of panels (12-18) joined together to form a sleeve (64). The panels (12-18) each have an end edge that cooperate to define an imaginary plane (P) at one end of the sleeve (64). The container (10) further has an end panel (20,22) connected to the panels (12-18) at the one end of the sleeve (64). The end panel (20,22) has at least one portion extending beyond the imaginary plane (P). The supporting box (100) is provided to support the container (10). A hanger system (150) is provided and is attached to the box (100). The hanger system (150) supports an upper portion of the container (10) within the box (100). The container (10) is also provided with a port closure (300) that provides both a sterile and gas permeable barrier.
Patent AU-2002335696-B2 (AU)
Title: Contoured knee brace frame
Inventor: NELSON KIM ALEX
IPC: A63B71/12
Filed: 2002-08-30
Granted: 2008-12-18
Abstract: The present invention provides an improved knee brace that is configured to improve comfort to the user and reduce interference with the natural motion of the user's leg. The knee brace has rigid upper and lower frames that are connected together by polycentric hinges. The rigid upper frame is contoured such that no rigid structure is located along the medial superior region of the thigh. The rigid upper and lower frames are secured to the leg using a plurality of straps.
Patent AU-2002338015-B2 (AU)
Title: Human CDR-grafted antibodies and antibody fragments thereof
Inventor: HOSAKA EMI
IPC: B65H31/36
Filed: 2002-08-30
Granted: 2008-02-07
Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.
Patent AU-2002338528-B2 (AU)
Title: Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
Inventor: GARVEY DAVID S
IPC: A61F2/82
Filed: 2002-05-01
Granted: 2008-01-24
Abstract: The invention describes novel compositions comprising nebivolol and/or at least one metabolite of nebivolol and at least one nitric oxide donor, and, optionally, at least one antioxidant or a pharmaceutically acceptable salt thereof, and/or at least one compound used to treat cardiovascular diseases or a pharmaceutically acceptable salt thereof, and/or at least one nitrosated compound used to treat cardiovascular diseases. The compounds and compositions of the invention can also be bound to a matrix. The nitric oxide donor is a compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and may preferably be isosorbide dinitrate and/or isosorbide mononitrate. The antioxidant may preferably be a hydralazine compound or a pharmaceutically acceptable salt thereof. The invention also provides methods for treating and/or preventing vascular diseases characterized by nitric oxide insufficiency; and for treating and/or preventing Raynaud's syndrome; and for treating and/or preventing cardiovascular diseases or disorders.
Patent AU-2002356273-B2 (AU)
Title: Telecommunications services apparatus for processing telephone communications
Inventor: WILSON JEFFREY
IPC: H04L12/58
Filed: 2002-11-29
Granted: 2008-01-17
Abstract: In a mobile telephone system, a call routing equipment such as an SMS Router (18) receives a routing information request signal (SRI_SM) indicative of a communication such as a text message intended for a mobile terminal (10), and returns a routing information response signal (False Response) indicative of the SMS Router (18) instead of being indicative of the intended mobile terminal (10). This allows processing (Copy sent via TCP/IP) of the resulting text message (MTForwardSM) by the SMS Router (18), such as archiving of the text message, sending the text message to an email address, and/or forwarding the text message to an alternative destination.
Patent AU-2003217058-B2 (AU)
Title: Method and apparatus for loading a container with a product
Inventor: BAKER JEREMY KEITH
IPC: B65B1/36
Filed: 2003-04-03
Granted: 2007-04-05
Abstract: There is provided a method of loading a container with a defined quantity of product comprising closing off a perforation in a perforated plate; directing powder into the closed-off perforation by the sweeping action of a first director blade spaced from said perforated plate; and transferring the contents of the perforation to said container. The method is characterized by relative rotary motion of the perforated plate and said first director blade. Suitable apparatus is also provided.
Patent AU-2003224878-B2 (AU)
Title: Synthetic glyco-lipo-peptides as vaccines
Inventor: KRANTZ MARK J
IPC: C07K14/195
Filed: 2003-04-09
Granted: 2009-07-09
Abstract: A glycolipopeptide comprising at least one disease-associated epitope, and characterized by at least one lipidated interior amino acid or by the presence of a MUC1 epitope, may be used in a vaccine, preferably in conjunction with a liposome.
Patent AU-2003245820-B2 (AU)
Title: Method for producing highly porous metallic moulded bodies close to the desired final contours
Inventor: LAPTEV ALEXANDER
IPC: B22F3/11
Filed: 2003-05-09
Granted: 2009-01-08
Abstract: The starting material, metal powder, is mixed with a place holder. The mixture is pressed to a green molding. It is subjected to conventional mechanical processing. The place holder material is removed thermally in air, vacuum or protective gas. The molding is then sintered.
Patent AU-2003275874-B2 (AU)
Title: Drive device
Inventor: SOMMER FRANK-UWE
IPC: E05F15/10
Filed: 2003-06-05
Granted: 2009-04-23
Abstract: The drive mechanism, e.g. for gates and garage doors etc., has a guide rail (3) in the direction of gate/door movement for a moving slide (4) with an electromotor to operate the gate/door. The motor has connections to the electrical power supply (12), fed in at one end (7,9) of the guide rail. The electrical connection is a plug (8) with a cable (11), which can be connected at either end of the guide rail.
Patent AU-2004269131-B2 (AU)
Title: Device for detecting biochemical activity containing gap junctions
Inventor: GOOSSENS JOHN
IPC: G01N33/552
Filed: 2004-08-17
Granted: 2010-04-29
Abstract: A device for spatially separating a biochemical activity from a detection reaction that detects the biochemical activity. The device comprises a first membrane body comprising the biochemical activity, and a second membrane body comprising the detection reaction. The first and second membrane bodies each comprise lipid bilayers, wherein the first and second membrane bodies are connected by gap junctions.
Patent AU-2004278525-B2 (AU)
Title: Method for forming a polymer film on a surface that conducts or semiconducts electricity by means of electrografting, surfaces obtained, and applications thereof
Inventor: GONZALEZ JOSE
IPC: C09D5/44
Filed: 2004-09-28
Granted: 2009-12-17
Abstract: The invention relates to a method for forming a polymer film on a surface that conducts or semiconducts electricity by means of electrografting. Said method uses an electrolytic solution containing a selected quantity of Bronsted acid. This invention also relates to the electrically conductive or semiconductive surfaces obtained by means of said method.
Patent AU-2004283626-B2 (AU)
Title: Synbiotic composition for infants
Inventor: KNOL JAN
IPC: A23L33/00
Filed: 2004-10-25
Granted: 2010-07-15
Abstract: There is provided a preparation comprising  Bifidobacterium breve  and a mixture of non-digestible carbohydrates for non- or partially breast-fed infants as well as the use thereof for the treatment or prevention of immune disorder in non- or partially breast-fed infants. Also provided herein are sequence primers and probe for the detection of  Bifidobacterium  species as well as diagnostic kit thereof.
Patent AU-2005235161-B2 (AU)
Title: Devices and methods for anastomosis
Inventor: HOEDEMAKER HENDRIK OTHMAR TEN CATE
IPC: A61B17/00
Filed: 2005-04-20
Granted: 2011-03-24
Abstract: The invention relates to medical devices, in particular condoms/ drains, that find use in anastomosis. Thus the present invention relates to these medical devices per se, to a medical kit comprising these medical devices, to the use of these medical devices, to a method for medical treatment involving application of these medical devices to an organism who is in need thereof as well as to the use of certain biocompatible, biodegradable synthetic polymers in the preparation of a medical device for the treatment of a disease or a condition which requires anastomosis.  The medical devices of the present invention are typically condom shaped and are used for the protection of anastomosis. The devices comprise a tubular shaped part which is made of a biocompatible, biodegradable polymer. The devices may be applied by stapling.
Patent AU-2006243787-B2 (AU)
Title: Adhesive for metal bonding applications
Inventor: DOE DANIEL K
IPC: C09J4/00
Filed: 2006-05-02
Granted: 2010-09-16
Abstract: Adhesive formulations having acrylate monomer or methacrylate monomer, or mixtures thereof, and having a reducing agent and an initiator (e.g., peroxide). The formulations may include a chelating agent solution to improve storage stability and other properties. Further, the mole ratio of the initiator to the reducing agent may be adjusted to control weight loss of the adhesives during cure. Polyvinyl acetate or its derivatives may also be employed in the adhesive formulations to reduce weight loss during cure. Moreover, certain embodiments of the formulations include a toughening- agent copolymer having a glass transition temperature (of at least one domain) that is lower than -50 °C (-58 °F).; These toughening-agent copolymers may be added to the adhesive formulations to improve impact strength and other properties of the cured adhesives at lower temperatures, e.g., -40 °C (-40 °F), while maintaining performance of the cured adhesives at higher temperatures, e.g., 82 °C (180 °F).
Patent AU-2006256947-B2 (AU)
Title: Apparatus and method for paint coating or varnish coating a coilable metal sheet
Inventor: BAR KAI K O
IPC: B05C3/12
Filed: 2006-06-06
Granted: 2011-04-21
Abstract: Apparatus for paint or lacquer coating of a sheet capable of coiling that has precisely one drive, which is assigned in effect to a second coiling mount, wherein essentially no further means of influencing the running characteristics of the sheet are provided for.
Patent AU-2006284506-B2 (AU)
Title: Methods of altering poppy characteristics
Inventor: COTTERILL PAUL J
IPC: A01H3/04
Filed: 2006-08-17
Granted: 2012-06-14
Abstract: The present invention relates to the use of sulfonylurea compounds to alter physical and/or growth characteristics of poppy plants.
Patent AU-2007224640-B2 (AU)
Title: Heterobicyclic Carboxamides as inhibitors for kinases
Inventor: ANDREA VAUPEL
IPC: C07D471/06
Filed: 2007-03-13
Granted: 2011-12-15
Abstract: The invention relates to novel compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.
Patent AU-2007231888-B2 (AU)
Title: Workstation deployment
Inventor: RADACK JEFFERY P
IPC: G06F9/445
Filed: 2007-11-09
Granted: 2011-07-14
Abstract: 5 Deployment of a workstation includes receiving data related to the computing environment of workstations, organizing the workstations into groups based on at least one selectable common attribute among the data, and producing a deployment schedule based on the groups. COMPUTER - 8 24 DEPLOYMENT DATABASE PROCESS DEPLOYMENT 20 26 SCHEDULE ENVIRONMENT WORKSTATION WORKSTATION COMPUTER COMPUTER COMPUTING COMPUTING ENVIRONMENT '14 14 ENVIRONMENT
Patent AU-2007246155-B2 (AU)
Title: Modulation of T helper cell-mediated immune responses
Inventor: GALLERY EILEEN D M
IPC: A61K39/395
Filed: 2007-04-27
Granted: 2013-02-07
Abstract: Provided herein are methods for modulating one or more of a T-helper cell or monocyte lineage cell-mediated immune response in a subject, the method comprises administering to the subject an effective amount of a compound which binds to surface membrane immunoglobulin D (smIgD). Also provided are methods of diagnosis of one or more of a T-helper cell or monocyte lineage cell-mediated immune disease, and compositions and kits for use in such methods.
Patent AU-2007252078-B2 (AU)
Title: Fragrance precursor
Inventor: ARDERIU GIRAME MARC
IPC: A61K8/41
Filed: 2007-03-29
Granted: 2012-05-24
Abstract: The invention relates to a compound of the following formula (I) X-CRRR wherein - R is an organic moiety having 6 to 24 carbon atoms; - R is H or an organic moiety having 6 to 24 carbon atoms; - R is X or OH; - X is a moiety of the following formula (II): or an ammonium or C-C alkyl ammonium salt of the moiety of formula (II); wherein - x is 0 or 1; - y is 0 or 1; - z is 0 or 1; - m is a number from 2 to 10; - n is a number from 0 to 10; - o is a number from 0 to 10; - R is H or a C-C alkyl group; - R is a C-C alkyl or alkenyl group or, if n or o is at least 1, a C-C acyl group; - R is H or R; - R is a C-C alkylene group. which is capable of delivering aldehyde-type or ketone-type fragrance compounds, providing a long-lasting release of said fragrance compounds. This compound can be incorporated into fiber conditioning compositions, such as hair conditioners and fabric softeners, to enhance the fragrance performance. The compound provides controlled release from the substrate where it has been deposited over an extended period of time.
Patent AU-2007254309-B2 (AU)
Title: Method and compositions for treating hematological malignancies
Inventor: REISER HANS C
IPC: A61P35/00
Filed: 2007-05-16
Granted: 2012-05-03
Abstract: A compound of formula (1), and/or its salts, tautomers or solvates is used to treat hematological malignancies. In an embodiment, an organic acid salt of compound 1 is provided for general use in treatment of neoplasms, and in a further embodiment the salt is stabilized with carbohydrate.
Patent AU-2007276768-B2 (AU)
Title: Sleeping bag and storage sack combination
Inventor: MICHAELIS SUSAN L
IPC: A47G9/08
Filed: 2007-07-24
Granted: 2013-12-05
Abstract: A storage sack (140) for a sleeping bag (130). An end (154) or other portion of the storage sack (140) includes a section (150) that is the same color, texture, material, and/or pattern as the liner (152) for the sleeping bag (130). In addition, information (158) regarding the sleeping bag (130) may be included on the storage sack (140), for example by screen printing the information on the storage sack. In this manner, a user does not have to open the sleeping bag (130) to know its contents.
Patent AU-2007331145-B2 (AU)
Title: Absorbent articles including a body fluid signaling device
Inventor: LONG ANDREW M
IPC: A61F13/42
Filed: 2007-10-10
Granted: 2013-10-17
Abstract: Wetness indicators may include alarm devices that are designed to assist parents or attendants in identifying a wet diaper condition early on. These devices produce either a visual or an audible signal. Many of these devices rely on electronics, which may increase the expense of the absorbent article. Further, electronic devices rely on electrical sources and may be prone to failure if not utilized for an extended period of time. The invention concerns a signaling device that does not appreciably increase the cost of the absorbent article, while providing a meaningful (e.g. visible indication of time passed since insult) signal to the caregiver without relying on an electrical source for operation.
Patent AU-2007332594-B2 (AU)
Title: Method and apparatus for reading a key profile
Inventor: ANDREOLA RENATO
IPC: G06V10/145
Filed: 2007-12-06
Granted: 2014-02-20
Abstract: A method for reading a key profile, characterised by: illuminating the shank of said key (4, 4') with diffused light; and collecting on a sensor (26) the image obtained in this manner in the direction of the axis of said shank.
Patent AU-2007332654-B2 (AU)
Title: 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
Inventor: YANG MINMIN
IPC: A61K31/502
Filed: 2007-12-04
Granted: 2013-06-20
Abstract: The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula (I) wherein R
Patent AU-2007353839-B2 (AU)
Title: Coating compositions
Inventor: STOPEK JOSHUA
IPC: A61F13/00
Filed: 2007-12-20
Granted: 2013-05-02
Abstract: The present disclosure provides compositions suitable for forming medical devices and coatings for medical devices, including sutures, which include a copolymer, at least one phosphorylcholine, and a fatty acid component. Sutures and other medical devices possessing such coatings are also provided.
Patent AU-2008200265-B2 (AU)
Title: Therapy for alpha-galactosidase A deficiency
Inventor: SELDEN RICHARD F
IPC: A61K48/00
Filed: 2008-01-18
Granted: 2012-06-28
Abstract: A therapeutic method whereby an individual suspected of having x-galactosidase A deficiency, such as Fabry disease, is treated either with (1) human cells that have been genetically modified to overexpress and secrete human a-gal A, or (2) purified human a-gal A obtained from cultured, genetically modified human cells.
Patent AU-2008208820-B2 (AU)
Title: 2- piperazin-1-yl-3H-imidazo[4,5-b]pyridine derivatives
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/496
Filed: 2008-01-24
Granted: 2012-09-20
Abstract: The present invention is concerned with novel compounds of formula (I) having fundic relaxating activity. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds.
Patent AU-2008211213-B2 (AU)
Title: Shrink film containing semi-crystalline polyamide, articles made therefrom, and process for making and using same
Inventor: AUSTIN EMMET
IPC: B65D65/40
Filed: 2008-01-29
Granted: 2013-09-05
Abstract: A multilayer, heat-shrinkable film has a semi-crystalline polyamide content of at least 35%, based on total film volume, a total free shrink at 185°F of at least 35 percent, and an FTIR Transmission Absorbance A
Patent AU-2008247144-B2 (AU)
Title: Process for preparing dorzolamide
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: C07D495/04
Filed: 2008-05-07
Granted: 2013-02-28
Abstract: There is provided a process for preparing dorzolamide and processes for preparing intermediates useful in the preparation of dorzolamide. In particular, there is provided a process for preparing an acetoamido sulfone of formula (viii) comprising oxidation of a hydroxysulfonamide of formula (vii) in the presence of an oxidizing agent selected from the group consisting of: a peracid, tert-butyl hydroperoxide, dimethyl dioxirane, selenium dioxide, m-phenanthroline di-N-oxide, nitric acid and hydrogen peroxide. There is also provided a process for preparing an acetoamidosulfone of formula (ix-a) comprising converting a hydroxysulfone of formula (viii) to the acetoamidosulfone of formula (ix-a) in the presence of acetonitrile and an acid. There is also provided a process for separating the cis- and trans-isomers of dorzolamide from a mixture of the trans-isomer of dorzolamide and the cis-isomer of dorzolamide comprising reacting the mixture of isomers with a carboxylic acid.
Patent AU-2008262058-B2 (AU)
Title: System and method for monitoring information related to sleep
Inventor: CZEISLER CHARLES A
IPC: G06F15/00
Filed: 2008-06-04
Granted: 2012-05-31
Abstract: A system configured to monitor ambient illumination experienced by a subject. In one embodiment, the system comprises an illumination sensor, a timer, and a storage module. The illumination sensor is configured to monitor an intensity of ambient illumination within two or more wavelength ranges by generating one or more output signals that convey information related to the intensity of ambient illumination within the two or more wavelength ranges. The timer is configured to indicate the passage of periods of time. The storage module is configured to store information related to the intensity of ambient illumination within the two or more wavelength ranges, as conveyed by the one or more output signals, for individual periods of time. The system is portable to be carried by the subject.
Patent AU-2008264187-B2 (AU)
Title: Method of screening candidate compounds for susceptibility to biliary excretion
Inventor: BROUWER KIM L R
IPC: C12N5/06
Filed: 2008-12-24
Granted: 2011-07-07
Abstract: Abstract 42 A method of screening a candidate compound in vitro for susceptibility to in vivo biliary excretion by an endogenous sinusoidal or canalicular transport system, or by both sinusoidal and canalicular transport systems, the method 5 comprising the steps of: (a) providing a culture of hepatocytes, the culture of hepatocytes comprising at least one bile canaliculus; (b) exposing a candidate compound to the culture; and (c) determining an amount of candidate compound in the at least one 10 bile canaliculus, the amount of the candidate compound in the at least one bile canaliculus indicating the susceptibility of the candidate compound to biliary excretion.
Patent AU-2008265801-B2 (AU)
Title: AZS refractory composition
Inventor: ANDERSON MICHAEL W
IPC: C04B35/101
Filed: 2008-06-17
Granted: 2013-09-05
Abstract: A refractory composition includes a first set of components and a colloidal silica binder. The first set of components includes alumina and zirconia. The colloidal silica binder is provided at 5 wt % to 20 wt % of the dry weight of the first set of components. The refractory composition includes 45 wt % to 75 wt % alumina, 15 wt % to 30 wt % zirconia, and 10 wt % to 30 wt % silica.
Patent AU-2008291426-B2 (AU)
Title: Catecholamine derivatives and prodrugs thereof
Inventor: PUSCHL ASK
IPC: A61P25/00
Filed: 2008-08-28
Granted: 2013-01-31
Abstract: The present invention relates to novel catecholamine derivatives of Formula (I), to processes for their preparation, pharmaceutical compositions containing them and to their use in therapy.
Patent AU-2008315409-B2 (AU)
Title: Constructs containing multiple expression cassettes for cancer therapy
Inventor: AMIT DORON
IPC: C12N15/11
Filed: 2008-10-23
Granted: 2013-10-31
Abstract: The present invention relates to the field of cancer treatment, particularly to a novel constructs useful for treating tumors expressing H19 and/or IGF-II. More specifically, the invention provides compositions and methods utilizing a nucleic acid construct enabling expression of a cytotoxic gene product directed by more than one tumor specific promoter.
Patent AU-2008337646-B2 (AU)
Title: Prevention of opportunistic infections in immune-compromised subjects
Inventor: SPRENGER NORBERT
IPC: A61K35/745
Filed: 2008-12-05
Granted: 2014-07-17
Abstract: This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic